All
Friday Frontline: Cancer Updates, Research and Education on October 25, 2019
October 25th 2019From the Food and Drug Administration’s call to action over breast implant-associated illness and lymphoma to a four-time survivor’s college football debut, here’s what is making headlines in the cancer space this week.
FDA Approves Zejula for Advanced Ovarian Cancer Subset
October 23rd 2019The Food and Drug Administration has approved Zejula for patients with advanced ovarian, fallopian tube, or primary peritoneal cancer that have been treated with three or more prior chemotherapy regimens and whose cancer is associated with homologous recombination deficiency-positive status.
New Genetic Testing Recommendations Could Improve Early Detection in Prostate Cancer
October 20th 2019Recent changes to the National Comprehensive Cancer Network (NCCN) guidelines around prostate cancer have updated the indications for genetic testing and have opened up a broader discussion on how it can be used to improve prostate cancer detection and treatment, according to Dr. James Mohler.